8-K

a50104184.htm

PFIZER INC. 8-K

UNITED

STATES

SECURITIES AND

EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES

EXCHANGE ACT OF 1934

Date

of Report (Date of earliest event reported): December 12, 2011

PFIZER

INC.

(Exact

name of registrant as specified in its charter)

Delaware

1-3619

13-5315170

(State or other jurisdiction

of incorporation)

(Commission File

Number)

(I.R.S. Employer

Identification No.)

235 East 42nd Street

New York, New York

10017

(Address

of principal

executive

offices)

(Zip

Code)

Registrant s telephone number, including area code:

(212)

733-2323

Not Applicable

(Former Name or Former Address,

if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to

simultaneously satisfy the obligation of the registrant under any of the

following provisions:

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR

230.425)

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR

240.14a-12)

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR

240.14d-2(b))

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR

240.13e-4(c))

Item 5.02

Departure of Directors or Certain Officers; Election of

Directors; Appointment of Certain Officers; Compensatory

Arrangements of Certain Officers.

On December 12, 2011, the Company s Board of Directors expanded the size

of the Board from 13 to 15 members. In addition, the Board of Directors

elected Dr. Marc Tessier-Lavigne and Dr. Helen Hobbs to serve as members

of the Board, effective immediately. Each has been provided an

indemnification agreement and will receive compensation in accordance

with the Company s standard arrangements for non-employee directors.

Separately, on December 12, 2011, Dr. Michael Brown, who has served as a

director of Pfizer since 1996, notified the Company of his intention to

retire from the Board at the Annual Meeting of Shareholders in April

2012.

Item 8.01

Other Events.

On December 12, 2011, the Company s Board of Directors elected current

President and Chief Executive Officer Ian Read as Chairman of the Board

and Chief Executive Officer, effective immediately. Mr. Read succeeds

George Lorch as Chairman of the Board. In addition, the independent

members of the Board elected Mr. Lorch to serve as the Company s Lead

Independent Director, also effective immediately.

A copy of the press release announcing the matters reported herein under

Items 5.02 and 8.01 is attached hereto as Exhibit 99.1. The information

contained in the press release is deemed to be filed under the

Securities Exchange Act of 1934, and such press release is incorporated

by reference in items 5.02 and 8.01 herein.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

99.1

Press Release dated December 12, 2011

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the

registrant has caused this report to be signed on its behalf by the

authorized undersigned.

PFIZER INC.

By:

/s/ Matthew Lepore

Matthew Lepore

Vice President and Corporate Secretary

Dated:

December 12, 2011

EXHIBIT INDEX

Number

Description

99.1

Press Release dated December 12, 2011

-->